197 related articles for article (PubMed ID: 29627798)
1. Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.
Khariton Y; Hernandez AF; Fonarow GC; Sharma PP; Duffy CI; Thomas L; Mi X; Albert NM; Butler J; McCague K; Nassif ME; Williams FB; DeVore A; Patterson JH; Spertus JA
Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004668. PubMed ID: 29627798
[TBL] [Abstract][Full Text] [Related]
2. Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
Kosiborod MN; Jhund PS; Docherty KF; Diez M; Petrie MC; Verma S; Nicolau JC; Merkely B; Kitakaze M; DeMets DL; Inzucchi SE; Køber L; Martinez FA; Ponikowski P; Sabatine MS; Solomon SD; Bengtsson O; Lindholm D; Niklasson A; Sjöstrand M; Langkilde AM; McMurray JJV
Circulation; 2020 Jan; 141(2):90-99. PubMed ID: 31736335
[TBL] [Abstract][Full Text] [Related]
3. Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.
Greene SJ; Butler J; Spertus JA; Hellkamp AS; Vaduganathan M; DeVore AD; Albert NM; Duffy CI; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
JAMA Cardiol; 2021 May; 6(5):522-531. PubMed ID: 33760037
[TBL] [Abstract][Full Text] [Related]
4. Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Butler J; Filippatos G; Jamal Siddiqi T; Brueckmann M; Böhm M; Chopra VK; Pedro Ferreira J; Januzzi JL; Kaul S; Piña IL; Ponikowski P; Shah SJ; Senni M; Vedin O; Verma S; Peil B; Pocock SJ; Zannad F; Packer M; Anker SD
Circulation; 2022 Jan; 145(3):184-193. PubMed ID: 34779658
[TBL] [Abstract][Full Text] [Related]
5. Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure.
Khariton Y; Nassif ME; Thomas L; Fonarow GC; Mi X; DeVore AD; Duffy C; Sharma PP; Albert NM; Patterson JH; Butler J; Hernandez AF; Williams FB; McCague K; Spertus JA
JACC Heart Fail; 2018 Jun; 6(6):465-473. PubMed ID: 29852931
[TBL] [Abstract][Full Text] [Related]
6. Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction: A Secondary Analysis of 2 Randomized Clinical Trials.
Pokharel Y; Khariton Y; Tang Y; Nassif ME; Chan PS; Arnold SV; Jones PG; Spertus JA
JAMA Cardiol; 2017 Dec; 2(12):1315-1321. PubMed ID: 29094152
[TBL] [Abstract][Full Text] [Related]
7. Change of Health-Related Quality of Life Over Time and Its Association With Patient Outcomes in Patients With Heart Failure.
Sepehrvand N; Savu A; Spertus JA; Dyck JRB; Anderson T; Howlett J; Paterson I; Oudit GY; Kaul P; McAlister FA; Ezekowitz JA;
J Am Heart Assoc; 2020 Sep; 9(17):e017278. PubMed ID: 32812460
[TBL] [Abstract][Full Text] [Related]
8. Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial.
Lewis EF; Kim HY; Claggett B; Spertus J; Heitner JF; Assmann SF; Kenwood CT; Solomon SD; Desai AS; Fang JC; McKinlay SA; Pitt BA; Pfeffer MA;
Circ Heart Fail; 2016 Mar; 9(3):e001937. PubMed ID: 26962133
[TBL] [Abstract][Full Text] [Related]
9. Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry.
Teramoto K; Tay WT; Tromp J; Katherine Teng TH; Chandramouli C; Ouwerkerk W; Lawson CA; Huang W; Hung CL; Chopra V; Anand I; Mark Richards A; Lam CSP
Circ Cardiovasc Qual Outcomes; 2023 Jan; 16(1):e009134. PubMed ID: 36484254
[TBL] [Abstract][Full Text] [Related]
10. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.
Joseph SM; Novak E; Arnold SV; Jones PG; Khattak H; Platts AE; Dávila-Román VG; Mann DL; Spertus JA
Circ Heart Fail; 2013 Nov; 6(6):1139-46. PubMed ID: 24130003
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and treatment preference for ventricular assist device therapy in ambulatory advanced heart failure: A report from the REVIVAL study.
Stehlik J; Mountis M; Haas D; Palardy M; Ambardekar AV; Estep JD; Ewald G; Russell SD; Robinson S; Jorde U; Taddei-Peters WC; Jeffries N; Richards B; Khalatbari S; Spino C; Baldwin JT; Mann D; Stewart GC; Aaronson KD;
J Heart Lung Transplant; 2020 Jan; 39(1):27-36. PubMed ID: 31822442
[TBL] [Abstract][Full Text] [Related]
12. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Greene SJ; Velazquez EJ; Anstrom KJ; Clare RM; DeWald TA; Psotka MA; Ambrosy AP; Stevens GR; Rommel JJ; Alexy T; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Eisenstein EL; Mentz RJ;
Circulation; 2023 Jul; 148(2):124-134. PubMed ID: 37212600
[TBL] [Abstract][Full Text] [Related]
13. Site-Level Variability in 30-Day Patient Outcomes After Transcatheter Mitral Valve Repair in the United States.
Malik AO; Chhatriwalla AK; Saxon J; Hejjaji V; Stebbins A; Jones PG; Cohen DJ; Arnold SV; Vemulapalli S; Wegermann ZK; Kosinski A; Spertus JA
Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e006878. PubMed ID: 33280434
[TBL] [Abstract][Full Text] [Related]
14. Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction.
Khariton Y; Fonarow GC; Arnold SV; Hellkamp A; Nassif ME; Sharma PP; Butler J; Thomas L; Duffy CI; DeVore AD; Albert NM; Patterson JH; Williams FB; McCague K; Spertus JA
JACC Heart Fail; 2019 Nov; 7(11):933-941. PubMed ID: 31521679
[TBL] [Abstract][Full Text] [Related]
15. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
Kosiborod MN; Verma S; Borlaug BA; Butler J; Davies MJ; Jon Jensen T; Rasmussen S; Erlang Marstrand P; Petrie MC; Shah SJ; Ito H; Schou M; Melenovský V; Abhayaratna W; Kitzman DW;
Circulation; 2024 Jan; 149(3):204-216. PubMed ID: 37952180
[TBL] [Abstract][Full Text] [Related]
16. Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department.
Stubblefield WB; Jenkins CA; Liu D; Storrow AB; Spertus JA; Pang PS; Levy PD; Butler J; Chang AM; Char D; Diercks DB; Fermann GJ; Han JH; Hiestand BC; Hogan CJ; Khan Y; Lee S; Lindenfeld JM; McNaughton CD; Miller K; Peacock WF; Schrock JW; Self WH; Singer AJ; Sterling SA; Collins SP
Circ Cardiovasc Qual Outcomes; 2021 Oct; 14(10):e007956. PubMed ID: 34555929
[TBL] [Abstract][Full Text] [Related]
17. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Chandra A; Vaduganathan M; Lewis EF; Claggett BL; Rizkala AR; Wang W; Lefkowitz MP; Shi VC; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV; Solomon SD;
JACC Heart Fail; 2019 Oct; 7(10):862-874. PubMed ID: 31302043
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).
McNaughton CD; McConnachie A; Cleland JG; Spertus JA; Angermann CE; Duklas P; Tromp J; Lam CSP; Filippatos G; Dahlstrom U; Dickstein K; Schweizer A; Perrone SV; Hassanein M; Ertl G; Obergfell A; Ghadanfar M; Collins SP
Eur J Heart Fail; 2022 Jun; 24(6):1020-1029. PubMed ID: 35429091
[TBL] [Abstract][Full Text] [Related]
19. Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial.
Peikert A; Chandra A; Kosiborod MN; Claggett BL; Desai AS; Jhund PS; Lam CSP; Inzucchi SE; Martinez FA; de Boer RA; Hernandez AF; Shah SJ; Janssens SP; Belohlávek J; Borleffs CJW; Dobreanu D; Langkilde AM; Bengtsson O; Petersson M; McMurray JJV; Solomon SD; Vaduganathan M
JAMA Cardiol; 2023 Jul; 8(7):684-690. PubMed ID: 37208998
[TBL] [Abstract][Full Text] [Related]
20. Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials.
Nassif ME; Windsor SL; Gosch K; Borlaug BA; Husain M; Inzucchi SE; Kitzman DW; McGuire DK; Pitt B; Scirica BM; Shah SJ; Umpierrez G; Austin BA; Lamba S; Khumri T; Sharma K; Kosiborod MN
Circ Heart Fail; 2023 Jul; 16(7):e009837. PubMed ID: 37203441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
